Welcome — and thank you for being one of the first people to open this. I started BH Leadership Brief for a simple reason: I wanted one quick, easy to read place that pulled together everything new in behavioral health that actually touches my job — and left out everything that doesn't. I spend my days as a leader on the inpatient psych side of behavioral healthcare, where a CMS rule change, a payer's prior-auth shift, or an unfilled psychiatrist line isn't theoretical — it directly shapes my everyday decision making. This is the read I always wanted: one place that pulls the federal and Colorado policy moves, the clinical and pharmacological developments, the technology and AI shifts, and the workforce signals worth knowing, and quietly skips the rest. No filler, no explaining your own job back to you — just the week's intelligence, sorted by what it changes for your operation, in about ten minutes. I'm glad you're here. Let's get into it.

Weekly intelligence for behavioral health leaders — policy, clinical innovation, technology, workforce, and the week ahead.

Medicaid work requirements stopped being a proposal this week — Montana and Arkansas went live July 1. Montana began enforcing the community-engagement requirement and Arkansas soft-launched eligibility checks on July 1, the first live tests of the CMS rule ahead of its July 31 effective date; the comment window on the interim final rule (docket CMS-2026-2047) also closes July 31 (KFF work-requirements tracker, updated June 2026; CBPP, June 2026).

Implication: These two states are the preview of your January 1 build — watch how their data matches handle SMI and SUD exemptions, because the failure modes will show up in coverage churn before they show up in policy guidance. If your functional-impairment documentation concerns aren’t in the docket yet, you have until July 31. CMS-relevant.

CoBHRM is live — Colorado’s consolidated behavioral health reporting model launched July 1. The BHA’s Colorado Behavioral Health Reporting Model went live in the Trails Measurement System on July 1, replacing duplicative mental health and SUD submissions with a single interface and aligning data elements with broader standards; BHASO-contracted providers work through their BHASO for specifications and transition support (Colorado BHA, July 2026).

Operational read: Cleaner in the long run, messy in the first cycle — mapping errors surface at the first submission batch, not in the spec documents. Get your data team and your BHASO on the same reject-resolution workflow now. Colorado BHA-relevant.

HCPF’s pediatric behavioral therapies changes also took effect July 1 — with a new claims requirement. Health First Colorado’s June provider bulletin details Pediatric Behavioral Therapies benefit changes effective July 1, including required ordering, prescribing, and referring (OPR) information on claims (HCPF Provider Bulletin B2600539, June 2026).

Operational read: Narrow but sharp: if any of your continuum touches PBT, claims without OPR data start denying now — this is a revenue-cycle configuration item, not a clinical one. HCPF-relevant.

Centanafadine posted positive phase 3 data in comorbid ADHD and anxiety — three weeks before its FDA date. New phase 3 results show the non-stimulant triple reuptake inhibitor improved ADHD symptoms in adults with comorbid anxiety, rounding out a program that spans pediatric, adolescent, and adult populations ahead of the July 24 PDUFA action date (Psychiatric Times, July 1).

Operational read: Comorbid anxiety is exactly where stimulant hesitancy is real on inpatient units — a clean label here strengthens the formulary watch-column case flagged last week. The abuse-liability language in the final label is still the thing to read first.

A single-dose LSD-based therapy just cleared a phase 3 bar in major depression. Definium Therapeutics’ DT120 (lysergide) ODT met its primary and all key secondary endpoints in the phase 3 Emerge trial — a single 100 µg dose produced an 8.1-point placebo-adjusted MADRS reduction at week 6 (Psychiatric Times pipeline review, June 30).

Operational read: The efficacy question is answered for now; the operational question isn’t. If this advances to an NDA, the monitoring and REMS architecture — observation windows, certified settings, staffing — will determine whether inpatient and PHP settings can actually deliver it. That’s the label fight to watch.

Bipolar depression got a genuinely new mechanism: elunetirom’s phase 2 readout was positive across the board. Autobahn Therapeutics’ brain-penetrant thyroid hormone receptor agonist met primary and all key secondary depression endpoints as an adjunctive treatment in bipolar I and II depression, with a favorable safety profile (Psychiatric Times pipeline review, June 30).

Operational read: Bipolar depression is where your formulary is thinnest and polypharmacy is worst — a novel-mechanism adjunct is worth a watch-column line even with phase 3 still ahead.

APA just drew the line on AI therapy — and put numbers on what your patients are already doing. The APA’s 2026 Chatbots and Mental Health Survey reports 77% of psychologists have patients using AI for support; 39% have patients self-diagnosing with AI, 36% see chatbot dependency, and 15% report patients developing delusional beliefs after chatbot use. A paired health advisory states generative AI should not be used for psychotherapy, diagnosis, or crisis support (APA, June 2026).

Implication: Patients now arrive having already “consulted” a chatbot — intake and safety assessments should ask about AI use the way they ask about substances, and document it. The delusional-belief signal is an inpatient presentation, not an outpatient curiosity; your clinicians will see it at intake before the literature catches up.

No second net-new item cleared the sourcing bar this week — the rest of the week’s AI coverage was vendor positioning, not operational news.

The Medicaid-driven contraction reached the Denver metro: Aurora Mental Health and Recovery cut 111 positions June 30. Aurora Mental Health and Recovery eliminated 111 positions effective June 30, citing Medicaid changes — 66 administrative and support roles, four direct client care; the same day, UMass Memorial’s Community Healthlink laid off 78, citing workforce shortages, inconsistent referrals, and declining demand (Becker’s Behavioral Health layoff tracker, June 2026).

Workforce read: The safety-net contraction is now local. Displaced clinical and administrative staff are in the Denver market this month — a hiring window if you have requisitions open — and if Aurora is in your referral network, expect access ripple effects on the front door. The 60-to-4 admin-to-clinical ratio in the cuts tells you where community BH margins actually broke.

The graduate loan caps are no longer a forecast — Grad PLUS ended and the caps took effect July 1. New federal graduate borrowing is now capped (roughly $20,500 per year and $100,000 lifetime for most master’s programs) and Grad PLUS is closed to new borrowers; students enrolled by June 30 with an existing Direct Loan are grandfathered for up to three academic years (Department of Education implementing rule, via Ensora Health, June 2026).

Workforce read: Flagged last week as a pipeline story — it’s now in effect. The grandfathering clause means the supply shock lands with the fall 2026 entering cohort: one cycle for programs and employers to stand up tuition-support and loan-assistance responses before applications reflect the new math.

•      July 13 — SAMHSA application deadlines converge: Behavioral Health and Community Safety Partnerships (SM-26-023) and SBIRT (TI-26-005) are both due, from the June 11 NOFO release.

•      July 24 — FDA target action date for centanafadine (non-stimulant ADHD) — this week’s comorbid-anxiety data raises the stakes on the label.

•      July 31 — CMS Medicaid community-engagement IFR effective date and comment-period close converge (docket CMS-2026-2047); Montana and Arkansas enforcement data starts accumulating now. Last window to comment. CMS-relevant.

•      Through August 15 — IPFQR DACA attestation window remains open in the HQR system for the FY2027 payment determination — confirm your QR team’s submission date is on the calendar. CMS-relevant.

•      Late July–early August — FY2027 IPF PPS final rule expected (proposed: +2.3% update, a 20% facility-level outlier-payment cap, a standardized patient assessment instrument, two IPFQR measures removed). The outlier cap is the sleeper — model your exposure before the final posts. CMS-relevant.

Everything that was “coming” in June went live this week — the work now is finding out which of your workflows didn’t notice.

Sources

–    KFF, Medicaid Work Requirements tracker and “An Early Look at Policy Decisions as States Get Ready to Implement Work Requirements” (Montana enforcement and Arkansas soft launch, July 1), updated June 2026

–    Center on Budget and Policy Priorities, “States Need More Time to Prepare for Medicaid Work Requirement,” June 2026

–    Colorado Behavioral Health Administration, Technology and Data Systems Support — CoBHRM launch July 1, 2026

–    HCPF, Health First Colorado Provider Bulletin B2600539 (Pediatric Behavioral Therapies changes and OPR requirement effective July 1, 2026), June 2026

–    Psychiatric Times, “Positive Phase 3 Data for Centanafadine to Treat Comorbid ADHD and Anxiety,” July 1, 2026

–    Psychiatric Times, “June 2026 in Review: Updates on the Psychiatric Treatment Pipeline” (DT120 Emerge phase 3; elunetirom AMPLIFY-BD phase 2), June 30, 2026

–    American Psychological Association, 2026 Chatbots and Mental Health Survey (“Patients Are Bringing AI to Therapy”) and accompanying health advisory, June 2026

–    Becker’s Behavioral Health, “6 Behavioral Health Layoffs to Know, 2026” (Aurora Mental Health and Recovery; Community Healthlink, effective June 30, 2026), June 2026

–    Ensora Health / U.S. Department of Education, graduate loan caps and Grad PLUS termination effective July 1, 2026

–    SAMHSA, NOFOs SM-26-023 and TI-26-005, applications due July 13, 2026

CMS, FY 2027 IPF PPS Proposed Rule fact sheet (CMS-1847-P), April 2, 2026

Make sure to subscribe so you don’t miss the next newsletter and you stay informed on the updates shaping behavioral healthcare in Colorado and the nation.